Semaglutide and NAION: Comprehensive Review of the Eye Safety Signal
Comprehensive review of semaglutide and non-arteritic anterior ischemic optic neuropathy synthesizes all available evidence on this potential GLP-1 drug eye safety concern.
Quick Facts
What This Study Found
Comprehensive review of semaglutide and non-arteritic anterior ischemic optic neuropathy synthesizes all available evidence on this potential GLP-1 drug eye safety concern.
Key Numbers
Review covers the original matched cohort study, subsequent unselected population studies, and a meta-analysis of clinical trials examining the semaglutide-NAION association.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Comprehensive review of semaglutide and non-arteritic anterior ischemic optic neuropathy synthesizes
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.
- Published In:
- Acta ophthalmologica, 103(6), 615-621 (2025)
- Authors:
- Amini, Abdullah, Hamann, Steffen(3), Larsen, Michael
- Database ID:
- RPEP-09927
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Comprehensive review of semaglutide and non-arteritic anterior ischemic optic neuropathy synthesizes all available evidence on this potential GLP-1 drug eye safety concern.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09927APA
Amini, Abdullah; Hamann, Steffen; Larsen, Michael. (2025). Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.. Acta ophthalmologica, 103(6), 615-621. https://doi.org/10.1111/aos.17473
MLA
Amini, Abdullah, et al. "Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.." Acta ophthalmologica, 2025. https://doi.org/10.1111/aos.17473
RethinkPeptides
RethinkPeptides Research Database. "Semaglutide and non-arteritic anterior ischaemic optic neuro..." RPEP-09927. Retrieved from https://rethinkpeptides.com/research/amini-2025-semaglutide-and-nonarteritic-anterior
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.